← Open Payments lookup

KRISTEN HALEY: Open Payments

NPI 1710506944 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$357 in 18 payments from 10 companies in 2025. Trend: 2023 $64 · 2024 $751 · 2025 $357

Food & beverage: $357
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.4$78
ABBVIE INC.3$51
Vanda Pharmaceuticals Inc.2$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$40
Axsome Therapeutics, Inc.2$38
Lundbeck LLC1$28
Otsuka America Pharmaceutical, Inc.1$22
Janssen Pharmaceuticals, Inc1$20
Alkermes, Inc.1$19
E.R. Squibb & Sons, L.L.C.1$19

Products named: VRAYLAR, REXULTI, AUSTEDO XR, FANAPT, CAPLYTA, Auvelity, UZEDY, SPRAVATO.

Industry payments across TX — which companies pay providers there.